Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youyuan Xu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Colloid and Interface Science|July 17, 2020
Controlled growth of AgI nanoparticles on hollow WO<sub>3</sub> hierarchical structures to act as Z-scheme photocatalyst for visible-light photocatalysisLihua Zhi, Shengya Zhang, Youyuan Xu, et al.
Analytica Chimica Acta|March 29, 2024
Microfluidic device featuring micro-constrained channels for multi-parametric assessment of cellular biomechanics and high-precision mechanical phenotyping of gastric cellsYang Heng, Xinyu Zheng, Youyuan Xu, et al.
Life Sciences|February 6, 2004
Differentially expressed genes in hypertensive rats developing cerebral ischemiaZhiming Zhu, Bin Zhao, Xianmei Wang, et al.
Molecular Endocrinology (Baltimore, Md.)|July 17, 2004
Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cellsDavid Masiello, Shao-Yong Chen, Youyuan Xu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2018
CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfallZenggang Pan, Mingyi Chen, Qianyun Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Combination of the mTOR inhibitor ridaforolimus and the anti-IGF1R monoclonal antibody dalotuzumab: preclinical characterization and phase I clinical trialSerena Di Cosimo, Sriram Sathyanarayanan, Johanna C Bendell, et al.
The Journal of Biological Chemistry|December 2, 2010
Genetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitorKumiko Nagashima, Stuart D Shumway, Sriram Sathyanarayanan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Colloid and Interface Science|July 17, 2020
Controlled growth of AgI nanoparticles on hollow WO<sub>3</sub> hierarchical structures to act as Z-scheme photocatalyst for visible-light photocatalysisLihua Zhi, Shengya Zhang, Youyuan Xu, et al.
Analytica Chimica Acta|March 29, 2024
Microfluidic device featuring micro-constrained channels for multi-parametric assessment of cellular biomechanics and high-precision mechanical phenotyping of gastric cellsYang Heng, Xinyu Zheng, Youyuan Xu, et al.
Life Sciences|February 6, 2004
Differentially expressed genes in hypertensive rats developing cerebral ischemiaZhiming Zhu, Bin Zhao, Xianmei Wang, et al.
Molecular Endocrinology (Baltimore, Md.)|July 17, 2004
Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cellsDavid Masiello, Shao-Yong Chen, Youyuan Xu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2018
CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfallZenggang Pan, Mingyi Chen, Qianyun Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Combination of the mTOR inhibitor ridaforolimus and the anti-IGF1R monoclonal antibody dalotuzumab: preclinical characterization and phase I clinical trialSerena Di Cosimo, Sriram Sathyanarayanan, Johanna C Bendell, et al.
The Journal of Biological Chemistry|December 2, 2010
Genetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitorKumiko Nagashima, Stuart D Shumway, Sriram Sathyanarayanan, et al.
Pageof 2